Summit Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-112.51-91.04-67.55-162.14
Price/Sales ratio
74.10197.7427.796.00
Earnings per Share (EPS)
$-0.22$-0.28$-0.37$-0.15

Historical Multiples (2016 – 2023)

2016 2017 2019 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-15.53-19.178.85-8.29-6.20-2.88-11.04-2.63-3.92K-6.20
Price/Sales ratio
N/A177.881.54313.34379.95137.161.16KN/A438.33313.34
Price/Book Value ratio
12.55-117.331.563.244.112.976.4820.812.444.11
Price/Cash Flow ratio
-15.4433.75-2.48-12.72-6.79-3.41-19.76-21.0616.31-12.72
Price/Free Cash Flow ratio
-15.3834.00-2.47-12.51-6.73-3.40-19.46-21.0316.01-12.51
Price/Earnings Growth ratio
3.33-3.93-0.050.03-0.01-0.120.18-0.01-0.04-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A100%99.95%75.41%100%100%-256.95%N/A33.30%100%
Operating Profit Margin
N/A-1078.68%21.94%-6766.38%-6185.23%-4764.28%-10235.62%N/A-7338.76%-6185.23%
Pretax Profit Margin
N/A-1115.75%11.69%-4494.85%-6152.32%-4897.84%-11185.93%N/A-11.16%-4494.85%
Net Profit Margin
N/A-927.56%17.49%-3779.07%-6127.55%-4762.13%-10561.05%N/A-11.16%-3779.07%
Effective Tax Rate
15.17%16.86%-49.61%15.92%0.40%2.77%5.58%0.15%N/A0.40%
Return on Assets
-68.14%-56.85%12.59%-31.65%-51.41%-75.98%-11.19%-302.99%-0.01%-31.65%
Return On Equity
-80.85%611.82%17.69%-39.08%-66.32%-103.43%-58.72%-791.49%-0.08%-39.08%
Return on Capital Employed
-92.25%-93.11%20.12%-65.23%-64.39%-98.21%-11.52%-49.15%-8.28%-65.23%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A4.40N/AN/AN/A16.934.40
Quick Ratio
6.383.053.636.273.923.519.159.298.996.27
Cash ratio
5.082.572.085.043.332.808.983.508.985.04
Days of Sales Outstanding
N/AN/AN/A3.05K4.32K295.38180.86N/A180.504.32K
Days of Inventory outstanding
N/AN/AN/A0.00N/AN/A43.77KN/AN/AN/A
Operating Cycle
N/AN/AN/A3.05KN/AN/A43.95KN/AN/AN/A
Days of Payables Outstanding
N/AN/A84.95K6.17KN/AN/A51.54474.85N/AN/A
Cash Conversion Cycle
N/AN/A-84.95K-3.11KN/AN/A43.90KN/AN/A-3.11K
Debt Ratios
Debt Ratio
N/AN/AN/A0.00N/A0.000.770.490.800.00
Debt Equity Ratio
N/AN/AN/A0.01N/A0.004.061.284.240.01
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.790.560.79N/A
Total Debt to Capitalization
N/AN/AN/A0.01N/A0.000.800.560.790.01
Interest Coverage Ratio
N/AN/AN/AN/A-205.23N/AN/AN/A-38.50-205.23
Cash Flow to Debt Ratio
N/AN/AN/A-24.60N/A-255.37-0.08-0.760.03-24.60
Company Equity Multiplier
1.18-10.761.401.231.291.365.242.615.241.23
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A5.26-0.62-24.62-55.94-40.12-59.04N/A26.86-24.62
Free Cash Flow / Operating Cash Flow Ratio
1.000.991.001.011.001.001.011.001.011.01
Cash Flow Coverage Ratio
N/AN/AN/A-24.60N/A-255.37-0.08-0.760.03-24.60
Short Term Coverage Ratio
N/AN/AN/A-24.60N/A-255.37-2.10N/A11.21-24.60
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A